user

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its…

6 years ago

Arcutis, Inc.’s ARQ-151 Development Program for Plaque Psoriasis

ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in…

6 years ago

International Cannabrands Announces Distribution Deal with Nabis

DENVER, CO / ACCESSWIRE / May 7, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce…

6 years ago

DECN’s Appeal Nearing Oral Arguments in its Patent Battle with Johnson & Johnson Over the Unjust Ruling in the Nevada Lower Court

Appeals Court Set to Hear and Then Decide DECN's Seminal Legal Question at Issue in Long Simmering Patent Battle with…

6 years ago

Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder

CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company…

6 years ago

VistaGen Therapeutics to Present at ChinaBio(R) Partnering Forum in Shanghai, China

SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing…

6 years ago

Evotec SE to Report First Quarter 2019 Results on 14 May 2019

HAMBURG, GERMANY / ACCESSWIRE / May 7, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report…

6 years ago

Preferred Dental Technologies Inc. (”Company”) (CSE: PDTI, US OTC: PDTTF): PDTI Receives 3D Patent Grant from US Patent and Trademark Office

WINNIPEG, MB / ACCESSWIRE / May 7, 2019 / Preferred Dental Technologies Inc. (PDTI) has been granted an additional patent…

6 years ago

Aytu BioScience to Report Fiscal Third Quarter 2019 Results and Business Update

Live Conference Call and Webcast Scheduled for May 14, 2019, at 9:00 a.m. ET ENGLEWOOD, CO / ACCESSWIRE / May…

6 years ago

Chinese Patent Office Issues Notice of Acceptance for Multiwavelength PhotoDynamic Therapy

TORONTO, ON / ACCESSWIRE / May 7, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),…

6 years ago

CTD Announces New Expanded Access Program in Taiwan using Trappsol Cyclo for Niemann-Pick Disease type C

Program is open to two patients who completed CTD's clinical trial with Trappsol® Cyclo™ in the United States ALACHUA, FL…

6 years ago

Apogenix to Present at Four Upcoming International Conferences

HEIDELBERG, GERMANY / ACCESSWIRE / May 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today…

6 years ago

Integrated BioPharma Names Christina Kay and Riva Sheppard as Co-Chief Executive Officers

HILLSIDE, NJ / ACCESSWIRE / May 6, 2019 / Integrated BioPharma, Inc. (OTCQB: INBP) (the "Company" or "INBP") announced today…

6 years ago

Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai

DURHAM, NC / ACCESSWIRE / May 6, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed…

6 years ago

Theralase’s Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study Research Presented at the American Urological Association

TORONTO, ON / ACCESSWIRE / May 6, 2019 / Theralase® Technologies Inc. (''Theralase'' or the ''Company'') (TSXV: TLT) (OTCQB: TLTFF),…

6 years ago

1933 Industries CEO Appointed as Chairman of the Board, Issuance of Bonus Shares and Investor Relations Contract

VANCOUVER, BC / ACCESSWIRE / May 3, 2019 / 1933 Industries Inc. (the 'Company' or '1933 Industries') (CSE: TGIF) (OTCQX:…

6 years ago

New Research Shows Who’s Worried About Drug Tests At Work

By Matt Zajechowski You don’t have to be a pilot or pro athlete to fear drug testing for your employer.…

6 years ago

Oncolytics Biotech (R) Reports 2019 First Quarter Financial Results and Operational Highlights

- Recent biomarker data identifies a simple blood test that may predict clinical response to pelareorep - - Interim data…

6 years ago

Oncolytics Biotech(R) Announces Voting Results from the Annual General Meeting of Shareholders

CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / May 3, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC),…

6 years ago

Invitation to MorphoSys Q1 2019 Conference Call on May 8, 2019

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 2, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; Nasdaq:…

6 years ago